Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 571

The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.

A Prospective, Single-Arm, Multicenter Trial of Catheter-Directed Mechanical Thrombectomy for Intermediate-Risk Acute Pulmonary Embolism

Open access
Tu, Thomas, Toma, Catalin, Tapson, Victor F., Adams, Christopher, Jaber, Wissam A., Silver, Mitchell, Khandhar, Sameer, Amin, Rohit, Weinberg, Mitchell, Engelhardt, Tod, Hunter, Monica, Holmes, David, Hoots, Glenn, Hamdalla, Hussam, Maholic, Robert L., Lilly, Scott M., Ouriel, Kenneth, Rosenfield, Kenneth·2019·JACC: Cardiovascular Interventions

Abstract

OBJECTIVES: The aim of this study was to evaluate the safety and effectiveness of percutaneous mechanical thrombectomy using the FlowTriever System (Inari Medical, Irvine, California) in a prospective trial of patients with acute intermediate-risk pulmonary embolism (PE). BACKGROUND: Catheter-directed thrombolysis has been shown to improve right ventricular (RV) function in patients with PE. However, catheter-directed thrombolysis increases bleeding risk and many patients with PE have relative and absolute contraindications to thrombolysis. METHODS: Patients with symptomatic, computed tomography-documented PE and RV/left ventricular (LV) ratios ≥0.9 were eligible for enrollment. The primary effectiveness endpoint was core laboratory-assessed change in RV/LV ratio. The primary safety endpoint comprised device-related death, major bleeding, treatment-related clinical deterioration, pulmonary vascular injury, or cardiac injury within 48 h of thrombectomy. RESULTS: From April 2016 to October 2017, 106 patients were treated with the FlowTriever System at 18 U.S. sites. Two patients (1.9%) received adjunctive thrombolytics and were analyzed separately. Mean procedural time was 94 min; mean intensive care unit stay was 1.5 days. Forty-three patients (41.3%) did not require any intensive care unit stay. At 48 h post-procedure, average RV/LV ratio reduction was 0.38 (25.1%; p < 0.0001). Four patients (3.8%) experienced 6 major adverse events, with 1 patient (1.0%) experiencing major bleeding. One patient (1.0%) died, of undiagnosed breast cancer, through 30-day follow-up. CONCLUSIONS: Percutaneous mechanical thrombectomy with the FlowTriever System appears safe and effective in patients with acute intermediate-risk PE, with significant improvement in RV/LV ratio and minimal major bleeding. Potential advantages include immediate thrombus removal, absence of thrombolytic complications, and reduced need for post-procedural critical care.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jcin.2018.12.022

Cites

26 of 26 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 26 references

Cited by

See all 571

Metadata

Authors
Tu, T., Toma, C., Tapson, V. F., Adams, C., Jaber, W. A., Silver, M., Khandhar, S., Amin, R., Weinberg, M., Engelhardt, T., Hunter, M., Holmes, D., Hoots, G., Hamdalla, H., Maholic, R. L., Lilly, S. M., Ouriel, K., & Rosenfield, K.
Venue
JACC: Cardiovascular Interventions
Publisher
Elsevier BV
Published
2019-05
Volume
12
Issue
9
Pages
859-869
ISSN
  • 1876-7605 (ISSN-L)
  • 1936-8798
OpenAlex
W2944591790
Cited by
571
References
26
FWCI
33.99
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A Prospective, Single-Arm, Multicenter Trial of Catheter-Directed Mechanical Thrombectomy for Intermediate-Risk Acute Pulmonary Embolism. https://app.cochat.ai/papers/10.1016/j.jcin.2018.12.022
The paper
Tu, T., Toma, C., Tapson, V. F., Adams, C., Jaber, W. A., Silver, M., Khandhar, S., Amin, R., Weinberg, M., Engelhardt, T., Hunter, M., Holmes, D., Hoots, G., Hamdalla, H., Maholic, R. L., Lilly, S. M., Ouriel, K., & Rosenfield, K. (2019). A Prospective, Single-Arm, Multicenter Trial of Catheter-Directed Mechanical Thrombectomy for Intermediate-Risk Acute Pulmonary Embolism. JACC: Cardiovascular Interventions. https://doi.org/10.1016/j.jcin.2018.12.022

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.